Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Repurposing anti-cancer drugs for COVID-19 treatment
Nicholas Borcherding
, Yogesh Jethava
, Praveen Vikas
Division of Laboratory and Genomic Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
32
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Repurposing anti-cancer drugs for COVID-19 treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
20%
Allergy Disease
20%
Anticancer Drugs
100%
Cell Division
20%
Clinical Trials
20%
Compassionate Use
20%
Coronavirus
20%
COVID-19
100%
COVID-19 Pandemic
20%
De Novo Drug Discovery
20%
Drug Development
20%
Drug pipeline
20%
Drug Repurposing
20%
Effective Compounds
40%
Efficacy Evaluation
20%
Emergency Authorisation
20%
Existing Drugs
20%
Financial Hardship
20%
Host Microenvironment
20%
Human Life
20%
Infectious Diseases
20%
Inflammation
20%
Johns Hopkins University
20%
Novel Coronavirus Disease 2019
20%
Novel Vaccines
20%
Remdesivir
20%
Remdesivir Treatment
20%
Repurposing
100%
Resource Center
20%
Safety Assessment
20%
Social Hardship
20%
Treatment Trials
20%
Use Studies
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
14%
Anticarcinogen
100%
Clinical Trial
14%
Coronavirinae
100%
Diseases
100%
Drug Development
14%
Drug Discovery
28%
Drug Repositioning
14%
Inflammation
14%
Malignant Neoplasm
14%
Pandemic
14%
Remdesivir
28%
Repurposing
100%